• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于共识的印度寻常型天疱疮和落叶型天疱疮管理指南。

Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus Foliaceous.

作者信息

De Dipankar, Mehta Hitaishi, Shah Shikha, Ajithkumar Kidangazhiathmana, Barua Shyamanta, Chandrashekar Laxmisha, Chatterjee Manas, Gupta Vishal, Khandpur Sujay, Khullar Geeti, Kolalapudi Seetharam Anjaneyulu, Kumar Sheetanshu, Neema Shekhar, Pandhi Deepika, Poojary Shital, Rai Reena, Rajagopalan Murlidhar, Rao Raghavendra, Shah Bela, Singal Archana, Thakur Vishal, Vinay Keshavamurthy, Aggrawal Ashutosh, De Arka, Mukherjee Soham, Prinja Shankar, Mahajan Rahul, Handa Sanjeev

机构信息

Department of Dermatology, Venereology and Leprology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

Department of Dermatology and Venereology, Govenment Medical College, Kottayam, Kerala, India.

出版信息

Indian Dermatol Online J. 2024 Dec 26;16(1):3-24. doi: 10.4103/idoj.idoj_1059_24. eCollection 2025 Jan-Feb.

DOI:10.4103/idoj.idoj_1059_24
PMID:39850690
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11753534/
Abstract

Pemphigus is an autoimmune blistering disorder characterized by the presence of intraepidermal blisters and erosions, primarily affecting the mucosa and/or skin. There are no established Indian guidelines for the management of pemphigus, and Western guidelines cannot be directly applied due to differences in clinicodemographic profiles, comorbidities, and resource limitations. These guidelines aim to provide Indian dermatologists with evidence-based and consensus-driven recommendations for the management of pemphigus vulgaris (PV) and pemphigus foliaceous (PF), taking into account the unique challenges posed by the Indian healthcare setting. The guidelines focus on the comprehensive management of PV and PF, addressing diagnosis, treatment, monitoring, and follow-up. It is intended for dermatologists working in both outpatient and inpatient settings across India. The first draft of the guidelines was prepared by the writing group and then reviewed by 19 national experts in pemphigus management, including inputs from allied specialties. Areas with limited evidence or anticipated variation in recommendations were subjected to rounds of voting, with responses categorized as "strongly agree," "agree," "neutral," "disagree," or "strongly disagree." Suggestions were incorporated, and statements were revised until a mean agreement score of 4 or higher was reached across 16 key areas after four voting rounds. These guidelines offer a structured approach to managing pemphigus in India, addressing the need for region-specific recommendations that account for unique challenges such as resource constraints and specific comorbidities in Indian patients. They serve as a valuable resource for dermatologists treating pemphigus in a range of clinical settings.

摘要

天疱疮是一种自身免疫性水疱性疾病,其特征为表皮内水疱和糜烂,主要累及黏膜和/或皮肤。目前尚无印度制定的天疱疮管理指南,由于临床人口统计学特征、合并症和资源限制方面存在差异,西方指南无法直接应用。这些指南旨在为印度皮肤科医生提供基于证据且经共识驱动的寻常型天疱疮(PV)和落叶型天疱疮(PF)管理建议,同时考虑到印度医疗环境带来的独特挑战。该指南侧重于PV和PF的综合管理,涵盖诊断、治疗、监测和随访。其目标受众为在印度门诊和住院环境工作的皮肤科医生。指南初稿由编写组制定,随后由19位天疱疮管理领域的国内专家进行评审,其中包括来自相关专业的意见。对于证据有限或建议预期存在差异的领域进行了多轮投票,回应分为“强烈同意”“同意”“中立”“不同意”或“强烈不同意”。建议被纳入其中,声明也经过修订,直到四轮投票后在16个关键领域的平均同意得分达到4分或更高。这些指南为印度天疱疮的管理提供了一种结构化方法,满足了针对特定区域建议的需求,这些建议考虑到了印度患者面临的独特挑战,如资源限制和特定合并症。它们是在一系列临床环境中治疗天疱疮的皮肤科医生的宝贵资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/0b65ad6e493b/IDOJ-16-3-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/e2eeb18969ac/IDOJ-16-3-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/3c95ebfb564c/IDOJ-16-3-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/8eaf9d3a22c9/IDOJ-16-3-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/0b65ad6e493b/IDOJ-16-3-g020.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/e2eeb18969ac/IDOJ-16-3-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/3c95ebfb564c/IDOJ-16-3-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/8eaf9d3a22c9/IDOJ-16-3-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6331/11753534/0b65ad6e493b/IDOJ-16-3-g020.jpg

相似文献

1
Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus Foliaceous.基于共识的印度寻常型天疱疮和落叶型天疱疮管理指南。
Indian Dermatol Online J. 2024 Dec 26;16(1):3-24. doi: 10.4103/idoj.idoj_1059_24. eCollection 2025 Jan-Feb.
2
Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.比较天疱疮治疗指南:全身性皮质类固醇、利妥昔单抗和其他免疫抑制剂治疗的综述。
Clin Rev Allergy Immunol. 2021 Dec;61(3):351-362. doi: 10.1007/s12016-021-08882-1. Epub 2021 Aug 4.
3
Efficacy and safety of adjuvant immunoadsorption in pemphigus vulgaris and pemphigus foliaceus (IA-Pem Study): a multicentre randomized controlled trial.辅助免疫吸附治疗寻常型天疱疮和落叶型天疱疮的疗效和安全性(IA-Pem 研究):一项多中心随机对照试验。
Br J Dermatol. 2024 Apr 17;190(5):657-667. doi: 10.1093/bjd/ljad489.
4
Treatment of Pediatric Pemphigus Foliaceus.儿童落叶型天疱疮的治疗
Cureus. 2023 Sep 16;15(9):e45373. doi: 10.7759/cureus.45373. eCollection 2023 Sep.
5
Clinical characteristics and outcomes of autoimmune blistering diseases in Japan.日本自身免疫性水疱病的临床特征与转归
J Dermatol. 2025 Feb;52(2):299-308. doi: 10.1111/1346-8138.17518. Epub 2024 Oct 26.
6
Comparison of enzyme-linked immunosorbent assay test with immunoblot assay in the diagnosis of pemphigus in Indian patients.酶联免疫吸附试验与免疫印迹法在印度患者天疱疮诊断中的比较。
Indian J Dermatol Venereol Leprol. 2010 Jan-Feb;76(1):27-32. doi: 10.4103/0378-6323.58675.
7
Consensus on the treatment of autoimmune bullous dermatoses: pemphigus vulgaris and pemphigus foliaceus - Brazilian Society of Dermatology.自身免疫性大疱性皮肤病的治疗共识:寻常型天疱疮和落叶型天疱疮——巴西皮肤病学会
An Bras Dermatol. 2019 Apr;94(2 Suppl 1):20-32. doi: 10.1590/abd1806-4841.2019940206. Epub 2019 Jun 3.
8
Rituximab in Pemphigus Vulgaris: A Review of Monoclonal Antibody Therapy in Dermatology.利妥昔单抗治疗寻常型天疱疮:皮肤病学中单克隆抗体疗法的综述
Cureus. 2023 Jun 21;15(6):e40734. doi: 10.7759/cureus.40734. eCollection 2023 Jun.
9
A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996-2006).寻常型天疱疮和落叶型天疱疮患者的临床研究:一项11年回顾性研究(1996 - 2006年)
Clin Exp Dermatol. 2008 Aug;33(5):641-3. doi: 10.1111/j.1365-2230.2008.02881.x. Epub 2008 Jul 8.
10
Differences among Indian and European pemphigus patients based on demographics, clinical parameters and propensity for relapse: results of a prospective bicontinental cohort study.基于人口统计学、临床参数和复发倾向的印度和欧洲天疱疮患者差异:一项前瞻性的洲际队列研究结果。
Eur J Dermatol. 2023 Dec 1;33(6):642-647. doi: 10.1684/ejd.2023.4631.

引用本文的文献

1
Influence of CD16 (FcγRIII) Expression on Peripheral Blood Mononuclear Cells on Response to Treatment with Rituximab in Pemphigus: A Cross-Sectional Study.CD16(FcγRIII)在外周血单个核细胞上的表达对天疱疮患者使用利妥昔单抗治疗反应的影响:一项横断面研究
Indian Dermatol Online J. 2025 Jun 17;16(4):557-563. doi: 10.4103/idoj.idoj_891_24. eCollection 2025 Jul-Aug.
2
Rituximab in Pemphigus - Exploring the Less Frequently Travelled Terrains.利妥昔单抗治疗天疱疮——探索较少涉足的领域
Indian Dermatol Online J. 2025 Jun 27;16(4):537-538. doi: 10.4103/idoj.idoj_649_25. eCollection 2025 Jul-Aug.

本文引用的文献

1
Use of multivariant enzyme-linked immunosorbent assay (ELISA) in the diagnosis of autoimmune bullous disorders in a resource-limited setting: A single-center experience.在资源有限的环境中使用多变量酶联免疫吸附测定(ELISA)诊断自身免疫性大疱性疾病:单中心经验
Indian J Dermatol Venereol Leprol. 2025 May-Jun;91(3):300-304. doi: 10.25259/IJDVL_1195_2023.
2
Direct immunofluorescence on plucked hair outer root sheath can predict relapse in pemphigus vulgaris.拔取毛发外根鞘进行直接免疫荧光检查可预测寻常型天疱疮的复发。
Int J Dermatol. 2025 Feb;64(2):367-376. doi: 10.1111/ijd.17405. Epub 2024 Jul 31.
3
Comparison of the Clinical Efficacy of Rituximab Infusion and Dexamethasone-Cyclophosphamide Pulse Therapy and Their Effect on Serum Th1, Th2, and Th17 Cytokines in Pemphigus Vulgaris-A Prospective, Nonrandomized, Comparative Pilot Study.
利妥昔单抗输注与地塞米松-环磷酰胺冲击疗法治疗寻常型天疱疮的临床疗效比较及其对血清Th1、Th2和Th17细胞因子的影响——一项前瞻性、非随机、比较性试验研究
Indian Dermatol Online J. 2024 Apr 29;15(3):464-472. doi: 10.4103/idoj.idoj_558_23. eCollection 2024 May-Jun.
4
Construction and validation of an audio-visual tool to instruct caregivers of patients with pemphigus in photographing skin and oral cavity lesions during tele-consultation: A cross-sectional study.用于指导天疱疮患者护理人员在远程会诊期间拍摄皮肤和口腔病变的视听工具的构建与验证:一项横断面研究
Indian J Dermatol Venereol Leprol. 2025 Jan-Feb;91(1):76-80. doi: 10.25259/IJDVL_361_2023.
5
Differences among Indian and European pemphigus patients based on demographics, clinical parameters and propensity for relapse: results of a prospective bicontinental cohort study.基于人口统计学、临床参数和复发倾向的印度和欧洲天疱疮患者差异:一项前瞻性的洲际队列研究结果。
Eur J Dermatol. 2023 Dec 1;33(6):642-647. doi: 10.1684/ejd.2023.4631.
6
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.在利妥昔单抗作为一线治疗的天疱疮患者中,无皮质类固醇的持续缓解:Ritux 3 试验的随访。
JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679.
7
Rescue treatment with intravenous immunoglobulin and amniotic membrane dressing in refractory paediatric pemphigus vulgaris with sepsis.静脉注射免疫球蛋白和羊膜敷料治疗难治性儿童寻常型天疱疮合并脓毒症。
BMJ Case Rep. 2023 Aug 9;16(8):e253507. doi: 10.1136/bcr-2022-253507.
8
Serologic Biomarkers in Pemphigus Monitoring: C-reactive Protein, Macrophage Migration Inhibitory Factor, and Prolactin Levels Versus Autoantibody Assays.天疱疮监测中的血清学生物标志物:C 反应蛋白、巨噬细胞移动抑制因子和催乳素水平与自身抗体检测的比较。
Iran J Allergy Asthma Immunol. 2023 Jun 20;22(3):312-318. doi: 10.18502/ijaai.v22i3.13059.
9
Prophylaxis Against Pneumocystis jirovecii Pneumonia in Adults.成人耶氏肺孢子菌肺炎的预防
JAMA. 2023 Jul 11;330(2):182-183. doi: 10.1001/jama.2023.9844.
10
Association of Rituximab With Risk of Long-term Cardiovascular and Metabolic Outcomes in Patients With Pemphigus.利妥昔单抗与天疱疮患者长期心血管和代谢结局风险的关联。
JAMA Dermatol. 2023 Jan 1;159(1):56-61. doi: 10.1001/jamadermatol.2022.5182.